Yew Bio-Pharm Group, Inc.
YEWB · OTC
9/30/2021 | 6/30/2021 | 3/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$1,559 | -$548 | $2,912 | -$420 |
| Dep. & Amort. | $669 | $734 | $683 | $731 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | $6,032 | -$4,023 | -$4,108 | $3,183 |
| Other Non-Cash | $752 | $5,650 | -$264 | $1,635 |
| Operating Cash Flow | $5,895 | $1,813 | -$776 | $5,129 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$11,084 | -$4 | -$1,711 | -$6,269 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $5,442 | -$1,848 | $1,848 | -$6 |
| Investing Cash Flow | -$5,642 | -$1,852 | $137 | -$6,269 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$262 | $78 | $264 | $404 |
| Financing Cash Flow | -$262 | $78 | $264 | $404 |
| Forex Effect | -$129 | $1 | -$61 | $75 |
| Net Chg. in Cash | -$138 | $40 | -$436 | -$661 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $167 | $127 | $564 | $1,224 |
| End Cash | $28 | $167 | $127 | $564 |
| Free Cash Flow | -$5,189 | $1,809 | -$2,487 | -$1,139 |